https://charts.traderzeitung.de/phases/US81749D1072
string(1396) "{"isin":"US81749D1072","name":"Sera Prognostics Inc","stock_id_xnas":22560782,"stock_id_xnys":null,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.13,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.14,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":0.4695},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":2.11,"close_at":"2026-09-23 20:56:00","complete":true,"perf_pct":-1.4019},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"
Sera Prognostics

Sera Prognostics Aktie News & Nachrichten

[WKN: A3CU1F | Symbol: SERA]
Realtimekurs
   
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Sera Prognostics gefunden werden.

MT Newswires 19.08.2026 23:01 Uhr

Sera Prognostics ernennt Scott Gleason zum CFO

05:00 PM EDT, 19.08.2026 (MT Newswires) -- Sera Prognostics (SERA) hat Scott Gleason mit Wirkung zum 31. August zum Chief Financial Officer ernannt. E

MT Newswires 04.06.2026 13:29 Uhr

Craig-Hallum nimmt die Coverage für Sera Prognostics mit 'Kaufen'-Rating und einem Kursziel von $6 auf

07:28 AM EDT, 06/04/2026 (MT Newswires) -- http://www.mtnewswires.com Copyright © 2026 MT Newswires. All rights reserved. MT Newswires does not provid